These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12513683)

  • 1. The future of ECVAM: a personal perspective.
    Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():239-41. PubMed ID: 12513683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialogue and collaboration: a personal view on laboratory animal welfare developments in general, and on ECVAM's first decade in particular.
    Koëter HB
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():207-10. PubMed ID: 12513676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialogue and collaboration with ECVAM: the view of the EFPIA.
    Garthoff B
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():195-8. PubMed ID: 12513673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future activities: ECVAM and the quality control of biologicals.
    Cussler K; Halder M; Hendriksen C
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():225-6. PubMed ID: 12513681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ECVAM's response to the changing political environment for alternatives: consequences of the European Union chemicals and cosmetics policies.
    Hartung T; Bremer S; Casati S; Coecke S; Corvi R; Fortaner S; Gribaldo L; Halder M; Roi AJ; Prieto P; Sabbioni E; Worth A; Zuang V
    Altern Lab Anim; 2003 Nov; 31(5):473-81. PubMed ID: 15598174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECVAM, ECETOC and the EU chemicals policy.
    Botham PA
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():185-7. PubMed ID: 12513671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECVAM's role in the implementation of the Three Rs concept in the field of biologicals.
    Hendriksen C; Cussler K; Halder M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():41-6. PubMed ID: 12513650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ECVAM workshops: a critical assessment of their impact on the development, validation and acceptance of alternative methods.
    Combes RD
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():151-65. PubMed ID: 12513668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECVAM'S activities in the EU candidate countries.
    Sladowski D; Halder M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():203-5. PubMed ID: 12513675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The establishment of ECVAM and its progress since 1993.
    Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():5-11. PubMed ID: 12513646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECVAM's activities on computer modelling and integrated testing.
    Worth AP
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():133-7. PubMed ID: 12513665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECVAM's activities in validating alternative tests for skin corrosion and irritation.
    Fentem JH; Botham PA
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():61-7. PubMed ID: 12572585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The principles of validation and the ECVAM validation process.
    Worth AP; Balls M
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EU research activities in alternative testing strategies: current status and future perspectives.
    Vanhaecke T; Snykers S; Rogiers V; Garthoff B; Castell JV; Hengstler JG
    Arch Toxicol; 2009 Dec; 83(12):1037-42. PubMed ID: 19908029
    [No Abstract]   [Full Text] [Related]  

  • 15. ECVAM's collaborations with academia.
    Clothier R
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():175-83. PubMed ID: 12513670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECVAM's research and validation activities in the fields of topical toxicity and human studies.
    Zuang V
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():119-23. PubMed ID: 12513662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECVAM's activities on biologicals.
    Halder M; Balls M; Hendriksen C; Cussler K
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():125-8. PubMed ID: 12513663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECVAM's contributions to the implementation of the Three Rs in the production and quality control of biologicals.
    Halder M; Hendriksen C; Cussler K; Balls M
    Altern Lab Anim; 2002; 30(1):93-108. PubMed ID: 11827574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaboration between ZEBET, FRAME, and ECVAM: FRAME's contribution to establishing the Three Rs in Europe.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37 Suppl 2():23-7. PubMed ID: 20105007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FRAME Annual Lecture. International co-operation: an essential requirement for replacing animal toxicity tests.
    Spielmann H
    Altern Lab Anim; 2001; 29(6):637-46; discussion 647-8. PubMed ID: 11709040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.